Chimerix

2003

Chimerix Announces Licensing Deal    

- Chimerix Obtains Rights to Cidofovir for Development of an Oral Drug to Treat Smallpox Infections -

SAN DIEGO, CA, September 12, 2003 - Chimerix Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, today… > Read More

Chimerix Awarded $36.1m NIH Grant To Develop Its Oral Drug For The Treatment Of Smallpox Infection    

- Company Also Closes $3.1M Private Equity Financing 

SAN DIEGO, CA, September 9, 2003 – Chimerix Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, today announced… > Read More